Perricone MD Acne Relief Maximum Strength Spot Gel
- Manufacturer
- THG Beauty USA LLC
- Effective date
- 2025-11-07
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 2
- Source
- full-release
- Hydrated at
- 2026-06-01 01:42:30
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
Salicylic Acid 2%
OTC - PURPOSE SECTION
Acne Treatment
INDICATIONS & USAGE SECTION
For the treatment of acne
WARNINGS SECTION
For external use only.
OTC - WHEN USING SECTION
When Using this product skin irritation and dryness are more likely to occur if you use another topical acne medication at the same time.
■ If irritation occurs, only use one topical acne medication at a time.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
■ Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
DOSAGE & ADMINISTRATION SECTION
Directions
- Clean the skin thoroughly before applying this product.
- Cover the entire affected area with a thin layer one to three times daily.
- Because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times
daily if needed or as directed by a doctor.
- If bothersome dryness or peeling occurs, reduce application to once a day or every other day.
- Sensitivity Test for a New User Apply product sparingly to one or two small affected areas during the first 3 days. If no discomfort
occurs, follow the directions stated above.
INACTIVE INGREDIENT SECTION
Water/Aqua/Eau, SD Alcohol 40-B, Propanediol, Hamamelis Virginiana (Witch Hazel) Water, Glycerin, Citrulline, Sucrose, Hydroxyethylcellulose, Urea, Alcohol, Polysorbate 20, Panthenol, Sodium Hydroxide, Succinic Acid, Lactic Acid, Melaleuca Alternifolia (Tea Tree) Leaf Oil, Tetrasodium Glutamate Diacetate, Limonene
OTC - QUESTIONS SECTION
1-888-823-7837
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
DailyMed RxNorm Mappings#
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| f52be47f-7aa7-46c0-b1fa-50c18dd50206 | Product name | 1 | 20201029 |
| 444b3e50-f226-46ef-bfca-2e7035d140cd | Product name | 1 | 20190611 |
| dea2eded-d1e7-46bb-9a3d-f8dc20de6277 | Product name | 1 | 20190408 |
| 7cda52fc-125f-421c-8fea-bc1974370c49 | Product name | 2 | 20180703 |
| 597b1cfd-7b31-5048-62be-ca5cd740da2f | Product name | 1 | 20140508 |
| ec2149b3-5c6d-5344-f757-c86411073075 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 84448-538-14 | Perricone MD Acne Relief Maximum Strength Spot Gel | 1 in 1 CARTON | GEL | 1 | 2 | |
| 84448-538-14 | Perricone MD Acne Relief Maximum Strength Spot Gel | 14.1 g in 1 TUBE | GEL | 14.1 | 2 |
Products#
Every source-derived product name is available through these pages.
- Perricone MD Acne Relief Maximum Strength Spot Gel
- Salicylic Acid
- POLYSORBATE 20
- PANTHENOL
- GLYCERIN
- SUCROSE
- HYDROXYETHYL CELLULOSE, UNSPECIFIED
- CITRULLINE
- UREA
- WATER
- TETRASODIUM GLUTAMATE DIACETATE
- LACTIC ACID
- PROPANEDIOL
- WITCH HAZEL
- ALCOHOL
- LIMONENE, (-)-
- SUCCINIC ACID
- MELALEUCA ALTERNIFOLIA (TEA TREE) LEAF OIL
- SODIUM HYDROXIDE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 84448-538 | 84448-538-14 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Perricone MD Acne Relief Maximum Strength Spot Gel | SALICYLIC ACID | THG Beauty USA LLC | 1f92122d-4873-8c1a-e063-6294a90a1c3b | 2025-11-07 | Warnings | 84448-538-14 84448-538 84448053814 41d473fb-eac9-8976-e063-6394a90a684b 1f92122d-4873-8c1a-e063-6294a90a1c3b |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
